An FDA approved drug commonly used for malaria and rheumatoid arthritis showed considerable promise recently in improving the effectiveness of treatments already being used to fight malignant mesothelioma and other cancers.
More than 30 Phase I and Phase II Trials have shown that adding hydroxychloroquine


















Mesothelioma Lawsuit Reveals Rare Case of Sho...
Asbestos Awareness Group Details 2012 Asbesto...
Report: Cancer Deaths and Lung Cancer Deaths ...
ADAO Will Honor Mesothelioma Victim Steve McQ...
